SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form N-CSRS - Certified Shareholder Report, Semi-Annual:
SEC Accession No. 0001104659-20-024681
Filing Date
2020-02-25
Accepted
2020-02-25 14:17:38
Documents
4
Period of Report
2019-12-31
Effectiveness Date
2020-02-25

Document Format Files

Seq Description Document Type Size
1 N-CSRS tm205761-1_ncsrs.htm N-CSRS 264192
2 CERTIFICATIONS tm205761d1_ex99-cert.htm EX-99.CERT 21283
3 CERTIFICATIONS tm205761d1_ex99-906cert.htm EX-99.906CERT 7742
4 GRAPHIC tm205761-1_ncrsimg001.jpg GRAPHIC 2863
  Complete submission text file 0001104659-20-024681.txt   298697

Series and Classes/Contracts Information:

Existing
  Status Name Ticker Symbol
CIK 0001748197      
Series S000066138   INFUSIVE(R) COMPOUNDING GLOBAL EQUITIES ETF
Class/Contract C000213717   INFUSIVE(R) COMPOUNDING GLOBAL EQUITIES ETF
Mailing Address C/O INFUSIVE ASSET MANAGEMENT INC. 750 LEXINGTON STREET NEW YORK NY 10222
Business Address C/O INFUSIVE ASSET MANAGEMENT INC. 750 LEXINGTON STREET NEW YORK NY 10222 646-902-6865
Infusive US Trust (Filer) CIK: 0001748197 (see all company filings)

IRS No.: 000000000
Type: N-CSRS | Act: 40 | File No.: 811-23426 | Film No.: 20649867